VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

被引:2125
作者
Gerhardt, H
Golding, M
Fruttiger, M
Ruhrberg, C
Lundkvist, A
Abramsson, A
Jeltsch, M
Mitchell, C
Alitalo, K
Shima, D
Betsholtz, C
机构
[1] Univ Gothenburg, Dept Biochem Med, SE-40530 Gothenburg, Sweden
[2] Imperial Canc Res Fund, Endothelial Cell Biol Lab, London WC2A 3PX, England
[3] UCL, Wolfson Inst Biomed Res, London WC1E 6AU, England
[4] Haartman Inst, Mol Canc Biol Lab, Helsinki, Finland
[5] Biomedicum, Ludwig Inst Canc Res, Helsinki, Finland
[6] Univ Nottingham, City Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England
关键词
VEGF; endothelial cell; filopodia; astrocyte; migration; proliferation;
D O I
10.1083/jcb.200302047
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular endothelial growth factor (VEGF-A) is a major regulator of blood vessel formation and function. it controls several processes in endothelial cells, such as proliferation, survival, and migration, but it is not known how these are coordinately regulated to result in more complex morphogenetic events, such as tubular sprouting, fusion, and network formation. We show here that VEGF-A controls angiogenic sprouting in the early postnatal retina by guiding filopodial extension from specialized endothelial cells situated at the tips of the vascular sprouts. The tip cells respond to VEGF-A only by guided migration; the proliferative response to VEGF-A occurs in the sprout stalks. These two cellular responses are both mediated by agonistic activity of VEGF-A on VEGF receptor 2. Whereas tip cell migration depends on a gradient of VEGF-A, proliferation is regulated by its concentration. Thus, vessel patterning during retinal angiogenesis depends on the balance between two different qualities of the extracellular VEGF-A distribution, which regulate distinct cellular responses in defined populations of endothelial cells.
引用
收藏
页码:1163 / 1177
页数:15
相关论文
共 45 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS [J].
AUSPRUNK, DH ;
FOLKMAN, J .
MICROVASCULAR RESEARCH, 1977, 14 (01) :53-65
[3]   FORMATION OF CAPILLARY BASEMENT-MEMBRANES DURING INTERNAL VASCULARIZATION OF RATS CEREBRAL-CORTEX [J].
BAR, T ;
WOLFF, JR .
ZEITSCHRIFT FUR ZELLFORSCHUNG UND MIKROSKOPISCHE ANATOMIE, 1972, 133 (02) :231-+
[4]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[5]  
Bonanno E, 2000, IN VITRO CELL DEV-AN, V36, P336
[6]   VEGF gene therapy: stimulating angiogenesis or angioma-genesis? [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (10) :1102-1103
[7]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[8]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[9]  
Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500
[10]   Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 [J].
Dumont, DJ ;
Jussila, L ;
Taipale, J ;
Lymboussaki, A ;
Mustonen, T ;
Pajusola, K ;
Breitman, M ;
Alitalo, K .
SCIENCE, 1998, 282 (5390) :946-949